KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NovoCure (NVCR) Other Working Capital Changes (2016 - 2025)

NovoCure's Other Working Capital Changes history spans 12 years, with the latest figure at -$2.6 million for Q4 2025.

  • For Q4 2025, Other Working Capital Changes fell 115.05% year-over-year to -$2.6 million; the TTM value through Dec 2025 reached -$5.3 million, up 17.08%, while the annual FY2025 figure was -$5.3 million, 17.08% up from the prior year.
  • Other Working Capital Changes for Q4 2025 was -$2.6 million at NovoCure, down from -$2.4 million in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $920000.0 in Q2 2025 and bottomed at -$4.4 million in Q1 2021.
  • The 5-year median for Other Working Capital Changes is -$1.9 million (2021), against an average of -$2.0 million.
  • The largest annual shift saw Other Working Capital Changes plummeted 1852.89% in 2021 before it surged 150.3% in 2025.
  • A 5-year view of Other Working Capital Changes shows it stood at -$2.2 million in 2021, then grew by 24.89% to -$1.7 million in 2022, then dropped by 10.67% to -$1.8 million in 2023, then soared by 33.46% to -$1.2 million in 2024, then crashed by 115.05% to -$2.6 million in 2025.
  • Per Business Quant, the three most recent readings for NVCR's Other Working Capital Changes are -$2.6 million (Q4 2025), -$2.4 million (Q3 2025), and $920000.0 (Q2 2025).